(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

COMBINAÇÕES DE POZIOTINIBE COM UM ANTICORPO ANTI-HER1, HER2 OU HER4 E MÉTODOS DE USO DAS MESMAS

ArquivadaInvention PatentPCT · US2019038974

Application data

Number

112020026382

Type

Invention Patent

Filing

06/25/2019

Publication

03/23/2021

PCT

US2019038974

Progress at the INPI

  1. Filing06/25/19
  2. Publication03/23/21
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: examination was not requested within the 36 months following the 06/25/2019 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 12/20/2022. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

HANMI PHARMACEUTICAL CO., LTD

KR

SPECTRUM PHARMACEUTICALS, INC.

CA

See this company's full portfolio

Inventors

G. R. (pessoa física)

US

J. B. (pessoa física)

KR

S. J. (pessoa física)

KR

Technical data

Priority claims

US

62/689,282 · 06/25/2018

US

62/812,656 · 03/01/2019

Abstract

Trata-se de combinações de poziotinibe e um anticorpo anti-HER1, anti-HER2 ou anti-HER4, opcionalmente, com outros agentes e o uso das combinações para tratamento contra câncer.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento definitivo - Art. 33 da LPI

#11.1.1

12/20/2022

RPI 2711

Arquivamento - Art. 33 da LPI

#11.1

10/04/2022

RPI 2700

Notificação de entrada na fase nacional - PCT

#1.3

03/23/2021

RPI 2620

Alteração de dados cadastrais

#1.1

01/05/2021

RPI 2609

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.